Colorectal Neoplasms: all 5,734 studies
Page 55 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
- Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver MetastasesCompletedNCT00242086Not applicable
- Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal CancerCompletedNCT00238381Phase 3
- Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHABCompletedNCT00236249Phase 3
- A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Promoting Physical Activity After Colorectal CancerCompletedNCT00230646Phase 3
- Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerCompletedNCT00230399Phase 2
- Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel FunctionTerminatedNCT00229567Not applicable
- Survey of ColoRectal Cancer Education and Environment NeedsCompletedNCT00229554
- Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer PatientsCompletedNCT00228189Phase 1/2
- Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal CancerCompletedNCT00227747Phase 3
- Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00227734Phase 2
- Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal CancerStatus unknownNCT00225641Not applicable
- CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer SyndromeCompletedNCT00224601Phase 2
- Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal CancerStatus unknownNCT00220246
- Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal CancerCompletedNCT00220155Phase 2
- Molecular Markers of Prognosis in Colorectal Cancer PatientsCompletedNCT00220142
- Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerCompletedNCT00220116Phase 2
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00217711Phase 1/2
- Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid CarcinomaTerminatedNCT00216424Phase 4
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNCT00215982Phase 2
- XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal CancerStatus unknownNCT00215722Phase 2
- XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00212615Phase 2/3
- Patients Preference for Oral or i.v. TherapyCompletedNCT00212589Phase 3
- Randomized Phase III Adjuvant Study for Stage III Colorectal CancerStatus unknownNCT00209742Phase 3
- Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal CancerTerminatedNCT00209703Phase 2
- Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal CancerStatus unknownNCT00209651Phase 2
- Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal CancerCompletedNCT00209625Phase 1/2
- Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal CancerCompletedNCT00208546Phase 3
- Intensified Chemotherapy in CRC After Resection of Liver MetastasesCompletedNCT00208260Phase 2/3
- 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in OncologyCompletedNCT00207298
- An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal CancerCompletedNCT00207155Phase 1
- BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal MalignanciesCompletedNCT00207051Phase 1
- Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal CancerCompletedNCT00205322Phase 2
- Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal CancerCompletedNCT00202787Phase 2
- Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal CancerCompletedNCT00202774Phase 3
- Safety Study of Radio-labeled huA33 Antibody in Colorectal CancerCompletedNCT00199862Not applicable
- Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and IIICompletedNCT00199654Phase 3
- Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.Status unknownNCT00199277Phase 4
- Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver OnlyCompletedNCT00199173Phase 3
- Lactobacillus Rhamnosus in Prevention of Chemotherapy-related DiarrhoeaCompletedNCT00197873Not applicable
- Comparison of Fecal Ribonucleic Acid (RNA) Test With Fecal Occult Blood Test (FOBT) for Detecting Colorectal Cancer and AdenomaStatus unknownNCT00197405
- Weekly Topotecan in Patients Treated for Metastatic Colorectal CancerCompletedNCT00193167Phase 2
- A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)CompletedNCT00190515Phase 3
- Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to ChemotherapyStatus unknownNCT00189683Phase 3
- Celebrex With Preoperative Chemoradiation - Rectal CancerCompletedNCT00188565Phase 1/2
- Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After ChemotherapyCompletedNCT00188331
- Evaluation of Metabolic Activity of Liver Metastases by FDG-PET ScanningStatus unknownNCT00184782Not applicable
- Study of Xeloda and Gleevec in Patients With Advanced Solid TumorsCompletedNCT00183833Phase 1
- Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00182715Phase 3
- Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With CancerCompletedNCT00179348Not applicable
- Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
- Tumor-Pulsed Dendritic Cells Used as a Tumor VaccineTerminatedNCT00176761Phase 2
- Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal CancerStatus unknownNCT00173472
- Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to AgeStatus unknownNCT00173277
- Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in TaiwanStatus unknownNCT00172757
- Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal CancersStatus unknownNCT00172159Phase 2
- Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological TumorsCompletedNCT00168987Phase 4
- Stage IV Colorectal CA ALIMTACompletedNCT00166465Phase 1/2
- An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and OxaliplatinCompletedNCT00165867Phase 2
- Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal CancerCompletedNCT00165854Phase 2
- Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal CancerCompletedNCT00165568Phase 2
- Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00165217Phase 2
- Screening for Colorectal Neoplasm in First Degree Relatives of the AffectedCompletedNCT00164944
- Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal CancersStatus unknownNCT00164879Phase 3
- Colorectal Cancer Screening Intervention in UWPN ClinicsCompletedNCT00161460Not applicable
- Capecitabine and Gemcitabine in Patients With Metastatic Colorectal CancerCompletedNCT00159445Phase 2
- Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver MetastasesStatus unknownNCT00156975Phase 3
- Comparison of Laparoscopic Colectomy Versus Open Colectomy for Colorectal Cancer: … A Prospective Randomized TrialStatus unknownNCT00155727
- A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal CancersCompletedNCT00155558Phase 1
- Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 TreatmentStatus unknownNCT00154713Phase 1/2
- A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)CompletedNCT00152230Phase 3
- ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid TrialCompletedNCT00148226Phase 2
- A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal CancerCompletedNCT00147134Phase 3
- Do Patients With Colorectal Cancer Understand That Their Family is at Risk?TerminatedNCT00145860
- The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver MetastasesTerminatedNCT00145665Phase 1/2
- FLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerCompletedNCT00145314Phase 3
- FishGastro Study: Fish Consumption and Gastro-Intestinal HealthCompletedNCT00145015Not applicable
- Implementation of a New Strategy to Identify HNPCC PatientsStatus unknownNCT00141466Not applicable
- A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)TerminatedNCT00140894Phase 4
- Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).CompletedNCT00140036Phase 4
- Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsCompletedNCT00138060Phase 4
- Colorectal Cancer Control in Appalachian ChurchesWithdrawnNCT00137683Phase 2/3
- Promoting Colorectal Cancer Screening in Rural ColoradoCompletedNCT00137592Not applicable
- Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and WomenCompletedNCT00136227Not applicable
- Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsStatus unknownNCT00134758Phase 2/3
- CHOICE: Communicating Health Options Through Information and Cancer EducationCompletedNCT00134589Phase 4
- Circulating Tumor Cells in Patients With Metastatic Colorectal CancerStatus unknownNCT00133913
- An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
- Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma ProteinsTerminatedNCT00131586
- CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal CancerTerminatedNCT00129870Phase 4
- A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)TerminatedNCT00126451Phase 2
- Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal CancerCompletedNCT00126256Phase 3
- Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerCompletedNCT00123851Phase 2
- Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2/3
- The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer SurgeryCompletedNCT00122720Phase 4
- Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal CancerTerminatedNCT00120172Phase 2
- NORCCAP: Norwegian Colorectal Cancer Prevention TrialActive, not recruitingNCT00119912Not applicable
- Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal MetastasesCompletedNCT00119899Phase 3